Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis

Journal of Surgical Research

Volumn 190, Issue 1, 2014, Pages 55-63

  Bohanon, Fredrick J ^a   Wang, Xiaofu ^a   Ding, Chunyong ^a   Ding, Ye ^a   Radhakrishnan, Geetha L ^a   Rastellini, Cristiana ^a   Zhou, Jia ^a   Radhakrishnan, Ravi S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Apoptosis; Liver fibrosis; Oridonin; Stellate cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CYCLIN DEPENDENT KINASE 4; FIBRONECTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ORIDONIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FIBROGENESIS; HUMAN; HUMAN CELL; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; S PHASE CELL CYCLE CHECKPOINT; STELLATE CELL;

APOPTOSIS; LIVER FIBROSIS; ORIDONIN; STELLATE CELLS;

ACTINS; ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELLS, CULTURED; DITERPENES, KAURANE; EXTRACELLULAR MATRIX PROTEINS; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84902248209     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.03.036     Document Type: Article

References (27)

1. G.W. Neff, C.W. Duncan, and E.R. Schiff The current economic burden of cirrhosis Gastroenterol Hepatol (N Y) 7 2011 661
2. U.E. Lee, and S.L. Friedman Mechanisms of hepatic fibrogenesis Best Pract Res Clin Gastroenterol 25 2011 195
3. K. Asahina Hepatic stellate cell progenitor cells J Gastroenterol Hepatol 27 Suppl 2 2012 80
4. S. Lemoinne, A. Cadoret, H. El Mourabit, D. Thabut, and C. Housset Origins and functions of liver myofibroblasts Biochim Biophys Acta 1832 2013 948
5. H. Tsukamoto, N.L. Zhu, J. Wang, K. Asahina, and K. Machida Morphogens and hepatic stellate cell fate regulation in chronic liver disease J Gastroenterol Hepatol 27 Suppl 2 2012 94
6. Y. Liu, Z. Wang, and S.Q. Kwong et al. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib J Hepatol 55 2011 612
7. S.H. Lee, G.S. Seo, Y.N. Park, T.M. Yoo, and D.H. Sohn Effects and regulation of osteopontin in rat hepatic stellate cells Biochem Pharmacol 68 2004 2367
8. G.A. Ramm, R.W. Shepherd, and A.C. Hoskins et al. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment Hepatology 49 2009 533
9. W. Xu, J. Sun, and T.T. Zhang et al. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma Acta Pharmacol Sin 27 2006 1642
10. G. Chen, K. Wang, and B.Y. Yang et al. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells Int J Oncol 40 2012 139
11. C. Ding, Y. Zhang, and H. Chen et al. Oridonin ring a-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis J Med Chem 2013
12. H. Wang, Y. Ye, and J.H. Chui et al. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells Oncol Rep 24 2010 647
13. C.L. Zhang, L.J. Wu, S. Tashiro, S. Onodera, and T. Ikejima Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929 Biol Pharm Bull 27 2004 1527
14. C. Ding, Y. Zhang, and H. Chen et al. Novel nitrogen-enriched oridonin analogues with thiazole-fused a-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility J Med Chem 56 2013 5048
15. C. Ding, Y. Zhang, and H. Chen et al. Overcoming synthetic challenges of oridonin a-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position Org Lett 15 2013 3718
16. G.B. Zhou, H. Kang, and L. Wang et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo Blood 109 2007 3441
17. L. Xu, A.Y. Hui, and E. Albanis et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis Gut 54 2005 142
18. R. Hamid, Y. Rotshteyn, L. Rabadi, R. Parikh, and P. Bullock Comparison of alamar blue and MTT assays for high through-put screening Toxicol In Vitro 18 2004 703
19. M.M. Nociari, A. Shalev, P. Benias, and C. Russo A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity J Immunol Methods 213 1998 157
20. J.H. Kelly, and G.J. Darlington Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2 In Vitro Cell Dev Biol 25 1989 217
21. Y.F. Shi, Q. Zhang, and P.Y. Cheung et al. Effects of rhDecorin on TGF-β1 induced human hepatic stellate cells LX-2 activation Biochim Biophys Acta 1760 2006 1587
22. S. Dennler, S. Itoh, and D. Vivien et al. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene EMBO J 17 1998 3091
23. M. Ciciarello, R. Mangiacasale, and M. Casenghi et al. p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle J Biol Chem 276 2001 19205
24. Q. Cui, J.H. Yu, and J.N. Wu et al. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells Acta Pharmacol Sin 28 2007 1057
25. J. Sottile, and D.C. Hocking Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions Mol Biol Cell 13 2002 3546
26. A. Bentmann, N. Kawelke, and D. Moss et al. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function J Bone Miner Res 25 2010 706
27. N. Kawelke, M. Vasel, and C. Sens et al. Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-beta PLoS One 6 2011 e28181